Literature DB >> 2275932

When is it safe to stop patching?

J G Oster1, J W Simon, P Jenkins.   

Abstract

Prior reports indicate that about half of amblyopia patients successfully treated with occlusion subsequently require maintenance patching. This retrospective study was designed to discover what clinical characteristics might be associated with a stable outcome following primary occlusion. Included were 188 patients who: (1) had amblyopia related to strabismus, anisometropia or media opacity; and (2) were followed up for at least one year after successful primary occlusion. Patients who did not comply with treatment or who did not achieve equal vision were excluded. Their ages ranged from 2 to 119 months (mean 29 months). Eighty-eight patients (47%) who required no further occlusion were designated the clinically stable group (CSG). The remaining 100 (53%), who subsequently needed patching because of unequal acuities, constituted the maintenance patching group (MPG). CSG patients were older at the beginning (mean 33 months) and at the end (mean 40 months) of primary occlusion than were MPG patients (means 26 and 31 months). Primary occlusion was more likely to have been discontinued because of equal recognition acuities in CSG patients, while equal fixation behaviour or preferential looking was more likely in MPG patients. Distribution of diagnoses, severity of amblyopia at presentation, and length of follow-up were similar in the two groups. Visual outcomes at last follow-up were slightly better in the CSG (p = 0.002). We conclude that, in general, patching can be safely discontinued after the third birthday. Although follow-up after primary occlusion is important to ensure stable results in all patients, preverbal children are more likely to require maintenance patching.

Entities:  

Mesh:

Year:  1990        PMID: 2275932      PMCID: PMC1042272          DOI: 10.1136/bjo.74.12.709

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

1.  Stability of visual acuity in amblyopic patients after visual maturity.

Authors:  W E Scott; C F Dickey
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

2.  Esotropic children with amblyopia: effects of patching on acuity.

Authors:  A B Fulton; D L Mayer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

3.  Stimulus deprivation amblyopia in children. Sensitivity, plasticity, and elasticity (SPE).

Authors:  G B Jastrzebski; C S Hoyt; E Marg
Journal:  Arch Ophthalmol       Date:  1984-07

4.  Amblyopia: a long-term follow-up.

Authors:  J C Sparrow; J T Flynn
Journal:  J Pediatr Ophthalmol       Date:  1977 Nov-Dec

5.  Practical management of amblyopia.

Authors:  F C Ching; M M Parks; D S Friendly
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1986 Jan-Feb       Impact factor: 1.402

  5 in total
  7 in total

1.  The therapy of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two pooled data sets.

Authors:  J T Flynn; G Woodruff; J R Thompson; F Hiscox; W Feuer; J Schiffman; A Corona; L K Smith
Journal:  Trans Am Ophthalmol Soc       Date:  1999

2.  An inner city preschool visual screening programme: long-term visual results.

Authors:  R J Bowman; T H Williamson; R G Andrews; T C Aitchison; G N Dutton
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

3.  The therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data of published studies.

Authors:  J T Flynn; J Schiffman; W Feuer; A Corona
Journal:  Trans Am Ophthalmol Soc       Date:  1998

4.  Long term visual outcome in amblyopia treatment.

Authors:  J Ohlsson; M Baumann; J Sjöstrand; M Abrahamsson
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

5.  Factors affecting long term results of successfully treated amblyopia: initial visual acuity and type of amblyopia.

Authors:  S Levartovsky; M Oliver; N Gottesman; M Shimshoni
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

6.  Current concepts in the management of amblyopia.

Authors:  Blanca Ruiz de Zárate; Jaime Tejedor
Journal:  Clin Ophthalmol       Date:  2007-12

7.  Factors affecting the stability of visual function following cessation of occlusion therapy for amblyopia.

Authors:  Daniel J Tacagni; Catherine E Stewart; Merrick J Moseley; Alistair R Fielder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-18       Impact factor: 3.535

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.